151 related articles for article (PubMed ID: 28130753)
1. Fluctuation of ROS regulates proliferation and mediates inhibition of migration by reducing the interaction between DLC1 and CAV-1 in breast cancer cells.
Yang B; Zhu W; Zheng Z; Chai R; Ji S; Ren G; Liu T; Liu Z; Song T; Li F; Liu S; Li G
In Vitro Cell Dev Biol Anim; 2017 Apr; 53(4):354-362. PubMed ID: 28130753
[TBL] [Abstract][Full Text] [Related]
2. Flavone inhibits migration through DLC1/RhoA pathway by decreasing ROS generation in breast cancer cells.
Zhu W; Ma L; Yang B; Zheng Z; Chai R; Liu T; Liu Z; Song T; Li F; Li G
In Vitro Cell Dev Biol Anim; 2016 May; 52(5):589-97. PubMed ID: 26935193
[TBL] [Abstract][Full Text] [Related]
3. H2O2 inhibits proliferation and mediates suppression of migration via DLC1/RhoA signaling in cancer cells.
Ma L; Zhu WZ; Liu TT; Fu HL; Liu ZJ; Yang BW; Song TY; Li GR
Asian Pac J Cancer Prev; 2015; 16(4):1637-42. PubMed ID: 25743845
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis.
Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z
J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells.
Du X; Qian X; Papageorge A; Schetter AJ; Vass WC; Liu X; Braverman R; Robles AI; Lowy DR
Cancer Res; 2012 Sep; 72(17):4405-16. PubMed ID: 22693251
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol promotes oxidative stress to drive DLC1 mediated cellular senescence in cancer cells.
Ji S; Zheng Z; Liu S; Ren G; Gao J; Zhang Y; Li G
Exp Cell Res; 2018 Sep; 370(2):292-302. PubMed ID: 29964052
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1.
Sanchez-Solana B; Wang D; Qian X; Velayoudame P; Simanshu DK; Acharya JK; Lowy DR
Mol Cancer; 2021 Nov; 20(1):141. PubMed ID: 34727930
[TBL] [Abstract][Full Text] [Related]
8. DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.
Joshi R; Qin L; Cao X; Zhong S; Voss C; Min W; Li SSC
J Biol Chem; 2020 Jan; 295(2):645-656. PubMed ID: 31806702
[TBL] [Abstract][Full Text] [Related]
9. TBRG4 silencing promotes progression of squamous cell carcinoma via regulation of CAV-1 expression and ROS formation.
Wang J; Luo Q; Liu M; Zhang C; Jia Y; Tong R; Yang L; Fu X
Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):157-164. PubMed ID: 32415943
[TBL] [Abstract][Full Text] [Related]
10. Piper nigrum ethanolic extract rich in piperamides causes ROS overproduction, oxidative damage in DNA leading to cell cycle arrest and apoptosis in cancer cells.
de Souza Grinevicius VM; Kviecinski MR; Santos Mota NS; Ourique F; Porfirio Will Castro LS; Andreguetti RR; Gomes Correia JF; Filho DW; Pich CT; Pedrosa RC
J Ethnopharmacol; 2016 Aug; 189():139-47. PubMed ID: 27178634
[TBL] [Abstract][Full Text] [Related]
11. Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1.
Luanpitpong S; Talbott SJ; Rojanasakul Y; Nimmannit U; Pongrakhananon V; Wang L; Chanvorachote P
J Biol Chem; 2010 Dec; 285(50):38832-40. PubMed ID: 20923773
[TBL] [Abstract][Full Text] [Related]
12. DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism.
Yang X; Popescu NC; Zimonjic DB
Cancer Res; 2011 Apr; 71(8):2916-25. PubMed ID: 21372205
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration.
Heering J; Erlmann P; Olayioye MA
Exp Cell Res; 2009 Sep; 315(15):2505-14. PubMed ID: 19482022
[TBL] [Abstract][Full Text] [Related]
14. Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer.
Gökmen-Polar Y; True JD; Vieth E; Gu Y; Gu X; Qi GD; Mosley AL; Badve SS
PLoS One; 2018; 13(10):e0204658. PubMed ID: 30278072
[TBL] [Abstract][Full Text] [Related]
15. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
16. Restoration of DLC1 gene inhibits proliferation and migration of human colon cancer HT29 cells.
Wu PP; Jin YL; Shang YF; Jin Z; Wu P; Huang PL
Ann Clin Lab Sci; 2009; 39(3):263-9. PubMed ID: 19667410
[TBL] [Abstract][Full Text] [Related]
17. A novel small molecule compound diaporine inhibits breast cancer cell proliferation via promoting ROS generation.
Feng X; Yu W; Zhou F; Chen J; Shen P
Biomed Pharmacother; 2016 Oct; 83():1038-1047. PubMed ID: 27543689
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter.
Liu Y; Zhou J; Hu Y; Wang J; Yuan C
Mol Cell Biochem; 2017 Jan; 425(1-2):47-58. PubMed ID: 27830358
[TBL] [Abstract][Full Text] [Related]
19. Desacetyl nimbinene inhibits breast cancer growth and metastasis through reactive oxygen species mediated mechanisms.
Arumugam A; Subramani R; Nandy S; Powell S; Velazquez M; Orozco A; Galvez A; Lakshmanaswamy R
Tumour Biol; 2016 May; 37(5):6527-37. PubMed ID: 26637227
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 attenuates hydrogen peroxide-induced oxidative damage to lung carcinoma cells.
Suchaoin W; Chanvorachote P
Anticancer Res; 2012 Feb; 32(2):483-90. PubMed ID: 22287735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
